Octagon Therapeutics Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Calls On SyntheX, Autolus In Protei

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Pays $66M Up Front For Rights To La

The decision by US Congressional leaders to remove the Developing an Innovative Solution for Antimicrobial Resistant Microorganisms (DISARM) Act from the recent Coronavirus Aid, Relief, and Economic S

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bioph